HomeNewsClinical Trials

SMC unveils Cambridge Pharma

SMC unveils Cambridge Pharma

SMC, a solutions provider in the manufacturing of pharmaceutical and medical devices, announced the opening of Cambridge Pharma—a new business offering pharmaceutical development services, including sterile fill-finish. The new 20,000-sq ft facility located at the Cambridge Research Park, UK, includes a purpose-built sterile fill-finish facility, a process development laboratory and an analytical laboratory. Services include process development and scale up, sterile fill-finish for clinical trials, QC and stability testing and QP release of clinical trials supplies.

The sterile-fill finish facility is designed to meet up-to-date regulatory requirements and includes state-of-the-art dynamic and independent HVAC systems and two clean rooms. Each clean room is equipped with isolators and fill-finish equipment to support batch sizes from 100 units to 15,000 units in vials, cartridges, or syringes. Cambridge Pharma’s industrialisation engineers can take a customer’s laboratory scale formulation and develop a process for clinical trials in phases one to three including process development and filling of viscous formulations, suspensions, and gels. Non-standard primary drug containers can be accommodated, and container closure integrity tests and associated equipment can also be developed.

More news about: clinical trials | Published by Sudeep Soparkar | September - 07 - 2022 | 354

Last news about this category



We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members